Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy

Morita, Y; Kishino, Y; Fukuda, K; Tohyama, S

Tohyama, S (通讯作者),Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan.

CELL PROLIFERATION, 2022; 55 (8):

Abstract

Basic research on human pluripotent stem cell (hPSC)-derived cardiomyocytes (CMs) for cardiac regenerative therapy is one of the most active and compl......

Full Text Link